These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 855327)

  • 1. [Treatment of essential hypertension with prindolol].
    Kuska J; Sledzinski Z; Kokot F
    Wiad Lek; 1977 Apr; 30(7):505-10. PubMed ID: 855327
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of propranolol and prindolol in the treatment of essential hypertension.
    Beaton GR; Rosendorff C; Kramer R; Simpson RD
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):268-74. PubMed ID: 4208340
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 4. Viskaldix in the treatment of essential hypertension. A study on hospital out-patients.
    Cameron EG; Crowder D
    Practitioner; 1981 Apr; 225(1354):581-5. PubMed ID: 7279846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyldopa combined with prindolol in the treatment of severe hypertension.
    Seedat YK
    S Afr Med J; 1974 Aug; 48(38):1608-10. PubMed ID: 4615382
    [No Abstract]   [Full Text] [Related]  

  • 8. [M-mode echocardiographic evaluation of antihypertensive efficacy and the mechanism of action of pindolol].
    Bissoli GS; La Canna G; Zanini R; Caobelli A; Berra P; Ettori F; Arosio G
    Minerva Cardioangiol; 1985 Jun; 33(6):337-43. PubMed ID: 4047421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 10. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M; Winter-Fudurić ; Kuzmanić D
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Prindolol on intra-arterial pressure and plasma renin activity in essential hypertension].
    Oster P; Matthes D; Hüllemann KD
    Med Welt; 1976 Dec; 27(50):2435-7. PubMed ID: 1011973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pressor reaction of hypertonic subjects to physical exercise of submaximal intensity under the influence of beta-adrenergic block (Pindolol) (author's transl)].
    Chrástek J; Boudová L; Kavánková M; Benes K; Krízek V; Matousek O
    Sb Lek; 1973 Oct; 75(10):301-11. PubMed ID: 4759769
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of essential hypertension with pindolol].
    Kocemba J; Kawecka-Jaszcz K; Sniezek M; Starzycka M; Augustyński W
    Kardiol Pol; 1978; 21(3):201-8. PubMed ID: 691928
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with pindolol in African hypertensives.
    Abdullah MS
    East Afr Med J; 1983 Dec; 60(12):833-7. PubMed ID: 6676093
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cardiotropic effect of the beta receptor blockader Prindolol].
    Fiegel G
    Med Welt; 1975 Oct; 26(43):1989-9. PubMed ID: 1196090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.